Borrowings

12 Months Ended

Jun. 30, 2025

Schedule Of Borrowings

Borrowings

15. Borrowings

	2025		2025		2024
	US$		S$		S$
Current:
- Bank overdraft		48,251		61,371		-
- Lease liabilities		1,619,426		2,059,748		28,500
- Bank borrowings		-		-		2,677,856
		1,667,677		2,121,119		2,706,356
Non-current:
- Lease liabilities		1,020,801		1,298,357		-
- Bank borrowings		-		-		1,583,434
		1,020,801		1,298,357		1,583,434
		2,688,478		3,419,476		4,289,790

The breakdown of borrowings are as follows:

	2025		2025		2024
	US$		S$		S$
Term loan #1		-		-		206,695
Term loan #2		-		-		280,233
Term loan #3		-		-		178,565
Term loan #4		-		-		195,299
Term loan #6		-		-		531,708
Term loan #7		-		-		280,239
Term loan #9		-		-		322,818
Term loan #10		-		-		1,573,744
Term loan #11		-		-		691,989
Term loan #12		-		-		-
		-		-		4,261,290

Basel Medical Group Ltd. and its Subsidiaries

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For year ended June 30, 2025 and 2024

15. Borrowings (Continued)

The details of borrowings are as follows:

Term loan	Facility amount	Effective interest rate			Maturity date
			% p.a.
Term loan #1	S$600,000		2.50	%	October 2025
Term loan #2	S$1,000,000		2.75	%	October 2025
Term loan #3	S$600,000		2.75	%	November 2025
Term loan #4	S$700,000		2.50	%	November 2025
Term loan #6	S$1,400,000		2.25	%	April 2026
Term loan #7	S$1,000,000		2.75	%	October 2025
Term loan #9	S$850,000		2.25	%	April 2026
Term loan #10	S$600,000		2.75	%	November 2025
	S$1,000,000		3.00	%	November 2025
	S$500,000		2.50	%	March 2026
	S$529,890		1.53	%	December 2035
	S$501,670		1.53	%	December 2035
Term loan #11	S$400,000		2.25	%	January 2026
	S$1,500,000		2.50	%	December 2025
Term loan #12	S$4,000,000		4.30	%	One-month term, upon maturity

Term loan #1 to #12 was fully settled during the financial year, and as at June 30, 2025, there are no outstanding bank borrowings.

Basel Medical Group Ltd. and its Subsidiaries

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For year ended June 30, 2025 and 2024

15. Borrowings (Continued)

A reconciliation of liabilities arising from financing activities is as follows:

	Beginning of					Proceed from		Non-cash changes							End of
	financial year		Cash flows			bank borrowings		Addition		Accretion of interests		Other			financial period
		US$		US$			US$		US$		US$		US$			US$
June 30, 2025
Liabilities
Lease liabilities
- Current		22,407		(861,945	)		-		3,557,047		90,389		(1,188,472	)		1,619,426
- Non-current		-		-			-		-		-		1,020,801			1,020,801
Bank borrowings
- Current		2,105,398		(5,320,259	)		3,144,901		-		69,960		-			-
- Non-current		1,244,936		(1,244,936	)		-		-		-		-			-
		3,372,741		(7,427,140	)		3,144,901		3,557,047		160,349		(161,671	)		2,640,227

Basel Medical Group Ltd. and its Subsidiaries

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For year ended June 30, 2025 and 2024

15. Borrowings (Continued)

	Beginning of					Proceed from		Non-cash changes							End of
	financial year		Cash flows			bank borrowings		Addition		Accretion of interests		Other			financial year
	S$		S$			S$		S$		S$		S$			S$
June 30, 2025
Liabilities
Lease liabilities
- Current		28,500		(1,096,308	)		-		4,524,209		114,966		(1,511,619	)		2,059,748
- Non-current		-		-			-		-		-		1,298,357			1,298,357
Bank borrowings
- Current		2,677,856		(6,766,838	)		4,000,000		-		88,982		-			-
- Non-current		1,583,434		(1,583,434	)		-		-		-		-			-
		4,289,790		(9,446,580	)		4,000,000		4,524,209		203,948		(213,262	)		3,358,105
June 30, 2024
Liabilities
Lease liabilities
- Current		566,039		(553,000	)		-		-		15,461		-			28,500
- Non-current		28,500		-			-		-		-		(28,500	)		-
Bank borrowings
- Current		3,223,150		(2,517,707	)		-		-		160,777		1,811,636			2,677,856
- Non-current		3,395,070		-			-		-		-		(1,811,636	)		1,583,434
		7,212,759		(3,070,707	)		-		-		176,238		-			4,289,790

Basel Medical Group Ltd. and its Subsidiaries

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For year ended June 30, 2025 and 2024